Shee K, Jiang A, Varn FS, et al. Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER breast cancer. FASEB J. 2019;33(2):1644-1657. doi:10.1096/fj.201801241R
Eisenmann S, Bánffy E, van Dommelen P, et al. Reconciling material cultures in archaeology with genetic data: The nomenclature of clusters emerging from archaeogenomic analysis. Sci Rep. 2018;8(1):13003. doi:10.1038/s41598-018-31123-z
Currall BB, Chen M, Sallari RC, et al. Loss of LDAH associated with prostate cancer and hearing loss. Hum Mol Genet. 2018;27(24):4194-4203. doi:10.1093/hmg/ddy310
Schiff ER, Frampton M, Ben-Yosef N, et al. Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease. Hum Genet. 2018;137(9):723-734. doi:10.1007/s00439-018-1927-7
Kaminski JA, Schlagenhauf F, Rapp M, et al. Epigenetic variance in dopamine D2 receptor: a marker of IQ malleability? Transl Psychiatry. 2018;8(1):169. doi:10.1038/s41398-018-0222-7
Tan L, Xing D, Chang CH, Li H, Xie S. Three-dimensional genome structures of single diploid human cells. Science. 2018;361(6405):924-928. doi:10.1126/science.aat5641
Nishimasu H, Shi X, Ishiguro S, et al. Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science. 2018;361(6408):1259-1262. doi:10.1126/science.aas9129
Krishnan Y, Rees HA, Rossitto CP, et al. Green fluorescent proteins engineered for cartilage-targeted drug delivery: Insights for transport into highly charged avascular tissues. Biomaterials. 2018;183:218-233. doi:10.1016/j.biomaterials.2018.08.050
Rodrigues DN, Rescigno P, Liu D, et al. Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer. J Clin Invest. 2018;128(10):4441-4453. doi:10.1172/JCI121924
Shen K, Sabatini DM. Ragulator and SLC38A9 activate the Rag GTPases through noncanonical GEF mechanisms. Proc Natl Acad Sci U S A. 2018;115(38):9545-9550. doi:10.1073/pnas.1811727115